Third Harmonic Bio Stock (NASDAQ: THRD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 146.18K |
Day Range | - - - |
52 Wk Range | 5.77 - 16.94 |
Market Cap | $605.37M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 10.01% |
Days to Cover | 31.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Third Harmonic Bio (NASDAQ:THRD) through any online brokerage.
Other companies in Third Harmonic Bio’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Third Harmonic Bio has a consensus price target of $16.15.
The stock price for Third Harmonic Bio (NASDAQ: THRD) is $14.73 last updated September 19, 2024 at 4:00 PM EDT.
A quarterly cash dividend of 0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on August 15, 2014 to stockholders of record on August 6, 2014.
Third Harmonic Bio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Third Harmonic Bio.
Third Harmonic Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.